Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Completed · Phase 1
Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects of giving gemcitabine, doxorubicin, and paclitaxel together with carboplatin in treating patients with advanced bladder or kidney cancer and impaired kidney function.
Key facts
- Study ID
- NCT00003342
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 30
- Starts
- 1997-12-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2013-07-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- New York Weill Cornell Cancer Center at Cornell University — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.